EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Lead replacement due to non-infectious reasons in patients with cardiac resynchronization therapy in long-term follow-up

Ewa Jędrzejczyk-Patej iD, Michał Mazurek, Adam Sokal, Agnieszka Kotalczyk, Jakub Gumprecht, Jacek Kowalczyk, Patrycja Pruszkowska, Oskar Kowalski, Radosław Lenarczyk, Zbigniew Kalarus

ESC Heart Failure · 04.07.2026 · 13 (4)

DOI: 10.1093/eschf/xvag176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 22.06.2026. Verfasst von Ewa Jędrzejczyk-Patej und 9 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Cardiology and Angiology, Silesian Centre for Heart Diseases, Skłodowskiej-Curie 9, Zabrze 41-800, Poland. Hauptthemen laut MEDLINE: Heart Failure, Cardiac Resynchronization Therapy, Device Removal, Cardiac Resynchronization Therapy Devices. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Traditional cardiac resynchronization therapy (CRT) is an effective treatment for patients with heart failure.

Objective

The study aimed to determine the long-term durability of CRT leads, factors predisposing to lead replacement, and the outcomes of lead replacement in CRT patients.

Methods

The study population comprised 1059 consecutive patients who received conventional CRT implants at a university hospital between 2002 and 2019.

Results

During a median follow-up of 1661 days (interquartile range: 815–2792), a total of 324 leads were replaced in 251 patients (23.7%) for non-infectious reasons. The overall crude incidence of lead replacement was 19.4 events per 1000 lead-years. Of those who required lead replacement, 126 subjects (50.2%) underwent the procedure within the first year after CRT implantation. Among patients followed for more than 10 years (n = 143; 13.5%), 67 subjects (46.8%) had one or more lead replacements. Duration of the index CRT procedure and fluoroscopy time were independent predictors of lead replacement in a multivariable analysis [hazard ratio (HR) 1.03, 95% confidence interval (CI) 1.01–1.06, P = .02 and HR 1.11, 95% CI 1.02–1.15, P = .01, respectively]. The leads that required replacement were left ventricular (11.2%), right ventricular (10.8%), and right atrial (4%), corresponding to approximate rates of 21.4, 20.5, and 7.6 replacements per 1000 lead-years, respectively. Compared with no need for re-intervention, lead-related re-do procedures were not associated with overall long-term mortality (55.3% vs 51%, P = .3) or the incidence of device-related infective endocarditis (5.6% vs 4.5%, P = .82).

Conclusions

Almost 25% of patients with CRT require lead replacement during long-term follow-up for non-infectious reasons, and half of those require replacement within the first year. Over 10 years, nearly every second patient requires a lead-related redo procedure. Lead replacement was not associated with long-term all-cause mortality. Systematic proficiency-based training should be introduced as a routine strategy in the education of novice implanters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureCardiac Resynchronization TherapyDevice RemovalCardiac Resynchronization Therapy DevicesHumansFemaleFollow-Up StudiesMaleAgedTime FactorsRetrospective StudiesIncidenceMiddle Aged

Stichwörter der Autor:innen

Cardiac resynchronization therapyHeart failureLeadLead replacementOutcome

Autor:innen und Institutionen

  • 1st Department of Cardiology and Angiology, Silesian Centre for Heart Diseases, Skłodowskiej-Curie 9, Zabrze 41-800, Poland.
  • Department of Human Nutrition, Department of Dietetics, Faculty of Health Sciences, Medical University of Silesia, Katowice, Bytom, Poland.
  • Division of Medical Sciences in Zabrze, Department of Cardiology, Silesian Center for Heart Diseases, Medical University of Silesia, Katowice, Zabrze, Poland.

ORCID-Profile: Ewa Jędrzejczyk-Patej

Zitieren

APA

Jędrzejczyk-Patej, E., Mazurek, M., Sokal, A., Kotalczyk, A., Gumprecht, J., Kowalczyk, J., Pruszkowska, P., Kowalski, O., Lenarczyk, R., & Kalarus, Z. (2026). Lead replacement due to non-infectious reasons in patients with cardiac resynchronization therapy in long-term follow-up. ESC Heart Failure, 13(4). https://doi.org/10.1093/eschf/xvag176

Vancouver

Jędrzejczyk-Patej E, Mazurek M, Sokal A, Kotalczyk A, Gumprecht J, Kowalczyk J, et al. Lead replacement due to non-infectious reasons in patients with cardiac resynchronization therapy in long-term follow-up. ESC Heart Failure. 2026;13(4). doi:10.1093/eschf/xvag176

BibTeX
@article{JdrzejczykPatej2026,
  author = {Jędrzejczyk-Patej, Ewa and Mazurek, Michał and Sokal, Adam and Kotalczyk, Agnieszka and Gumprecht, Jakub and Kowalczyk, Jacek and Pruszkowska, Patrycja and Kowalski, Oskar and Lenarczyk, Radosław and Kalarus, Zbigniew},
  title = {Lead replacement due to non-infectious reasons in patients with cardiac resynchronization therapy in long-term follow-up},
  journal = {ESC Heart Failure},
  year = {2026},
  volume = {13},
  number = {4},
  doi = {10.1093/eschf/xvag176}
}
Kostenlos starten →